E.B.M. van Leeuwen - Concepedia

Author

E.B.M. van Leeuwen

Also Known As

E. B. M. van Leeuwen, E.B.M. van Leeuwen, Ellen B M van Leeuwen, Ellen B. M. Van Leeuwen, Ellen B.M. van Leeuwen

Publications

122

Citations

H-Index

Concepts

All Affiliations

E.B.M. van Leeuwen is an author at Maastricht University Medical Centre specializing in tumor biology, medicine, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	77
2	Immunology	3	3	77
3	Cell Biology	2	2	32
4	Immunotherapy	2	2	60
5	Pathology	1	1	45

E.B.M. van Leeuwen

Publications

111

Citations

H-Index

Page 1

	Year	Citations
Cancer specific Mucin‐1 glycoforms are expressed on multiple myeloma Silvie Cloosen, Jan‐Willem Gratama, E.B.M. van Leeuwen, British Journal of Haematology Hematological MalignancyTumor BiologyPlasma CellsDifferent Glycosylation ProfilesMedicine	2006	45
Aspirin Inhibits<b><i>Chlamydia pneumoniae</i></b>–Induced Nuclear Factor-κB Activation, Cytokine Expression, and Bacterial Development in Human Endothelial Cells Andreas Tiran, Hans‐Jürgen Gruber, Wolfgang F. Graier, Arteriosclerosis Thrombosis and Vascular Biology	2002	34
Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector E.B.M. van Leeuwen, Silvie Cloosen, Birgit L.M.G. Senden-Gijsbers, Cytotherapy Tumor BiologyHuman DcTumor Mucin-1Oncogenic AgentFiber-modified Adenoviral Vector	2006	17
Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC E.B.M. van Leeuwen, Silvie Cloosen, Birgit L.M.G. Senden-Gijsbers, Cytotherapy Cancer-associated VirusHuman DcImmunotherapyFiber-modified Adenoviral VectorMedicine	2006	15

Page 1